Therefore, the high activity of CFHR2 in PL in VS patients with severe to profound hearing loss could be related to altered barrier integrity, allowing more macromolecules and cell migration over the blood-perilymph barrier. This evidence concerns the gene CFHR2 and hearing loss disorder.